Akso Health Group (NASDAQ: AHG) Stock Competitors & Peer Comparison

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, VRSK has a market cap of 26.4B. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while VRSK trades at $201.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas VRSK's P/E ratio is 27.81. In terms of profitability, AHG's ROE is -0.34%, compared to VRSK's ROE of -21.38%. Regarding short-term risk, AHG is more volatile compared to VRSK. This indicates higher risk in terms of short-term price fluctuations for AHG.Check VRSK's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, CART has a market cap of 9.9B. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while CART trades at $42.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas CART's P/E ratio is 20.90. In terms of profitability, AHG's ROE is -0.34%, compared to CART's ROE of +0.16%. Regarding short-term risk, AHG is more volatile compared to CART. This indicates higher risk in terms of short-term price fluctuations for AHG.Check CART's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, TTD has a market cap of 8.1B. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while TTD trades at $17.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas TTD's P/E ratio is 15.72. In terms of profitability, AHG's ROE is -0.34%, compared to TTD's ROE of +0.17%. Regarding short-term risk, AHG is more volatile compared to TTD. This indicates higher risk in terms of short-term price fluctuations for AHG.Check TTD's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, MBGL has a market cap of 6.1B. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while MBGL trades at $20.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas MBGL's P/E ratio is 48.49. In terms of profitability, AHG's ROE is -0.34%, compared to MBGL's ROE of N/A. Regarding short-term risk, AHG is more volatile compared to MBGL. This indicates higher risk in terms of short-term price fluctuations for AHG.Check MBGL's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, NTSK has a market cap of 4.7B. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while NTSK trades at $11.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas NTSK's P/E ratio is -12.53. In terms of profitability, AHG's ROE is -0.34%, compared to NTSK's ROE of +31.50%. Regarding short-term risk, AHG is more volatile compared to NTSK. This indicates higher risk in terms of short-term price fluctuations for AHG.Check NTSK's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, TCGL has a market cap of 3.5B. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while TCGL trades at $172.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas TCGL's P/E ratio is -5761.33. In terms of profitability, AHG's ROE is -0.34%, compared to TCGL's ROE of -1.33%. Regarding short-term risk, AHG is less volatile compared to TCGL. This indicates lower risk in terms of short-term price fluctuations for AHG.Check TCGL's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, CSQR has a market cap of 3.5B. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while CSQR trades at $22.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas CSQR's P/E ratio is N/A. In terms of profitability, AHG's ROE is -0.34%, compared to CSQR's ROE of N/A. Regarding short-term risk, AHG is less volatile compared to CSQR. This indicates lower risk in terms of short-term price fluctuations for AHG.Check CSQR's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, KC has a market cap of 2.8B. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while KC trades at $9.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas KC's P/E ratio is -32.66. In terms of profitability, AHG's ROE is -0.34%, compared to KC's ROE of -0.12%. Regarding short-term risk, AHG is more volatile compared to KC. This indicates higher risk in terms of short-term price fluctuations for AHG.Check KC's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, KEEL has a market cap of 2.6B. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while KEEL trades at $4.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas KEEL's P/E ratio is N/A. In terms of profitability, AHG's ROE is -0.34%, compared to KEEL's ROE of -0.70%. Regarding short-term risk, AHG is less volatile compared to KEEL. This indicates lower risk in terms of short-term price fluctuations for AHG.Check KEEL's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, LFTO has a market cap of 2.2B. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while LFTO trades at $22.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas LFTO's P/E ratio is 58.26. In terms of profitability, AHG's ROE is -0.34%, compared to LFTO's ROE of N/A. Regarding short-term risk, AHG is more volatile compared to LFTO. This indicates higher risk in terms of short-term price fluctuations for AHG.Check LFTO's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, TRUE has a market cap of 225.9M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while TRUE trades at $2.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas TRUE's P/E ratio is -12.10. In terms of profitability, AHG's ROE is -0.34%, compared to TRUE's ROE of -0.12%. Regarding short-term risk, AHG is more volatile compared to TRUE. This indicates higher risk in terms of short-term price fluctuations for AHG.Check TRUE's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, AIB has a market cap of 133M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while AIB trades at $1.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas AIB's P/E ratio is -175.00. In terms of profitability, AHG's ROE is -0.34%, compared to AIB's ROE of -0.22%. Regarding short-term risk, AHG is less volatile compared to AIB. This indicates lower risk in terms of short-term price fluctuations for AHG.Check AIB's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, FIRY has a market cap of 127.4M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while FIRY trades at $8.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas FIRY's P/E ratio is -2.03. In terms of profitability, AHG's ROE is -0.34%, compared to FIRY's ROE of -0.55%. Regarding short-term risk, AHG is more volatile compared to FIRY. This indicates higher risk in terms of short-term price fluctuations for AHG.Check FIRY's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, ROC has a market cap of 84.1M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while ROC trades at $4.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas ROC's P/E ratio is -16.17. In terms of profitability, AHG's ROE is -0.34%, compared to ROC's ROE of -0.75%. Regarding short-term risk, AHG is less volatile compared to ROC. This indicates lower risk in terms of short-term price fluctuations for AHG.Check ROC's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, RSSS has a market cap of 73.6M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while RSSS trades at $2.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas RSSS's P/E ratio is 12.94. In terms of profitability, AHG's ROE is -0.34%, compared to RSSS's ROE of +0.27%. Regarding short-term risk, AHG is more volatile compared to RSSS. This indicates higher risk in terms of short-term price fluctuations for AHG.Check RSSS's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, ZGM has a market cap of 37.9M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while ZGM trades at $3.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas ZGM's P/E ratio is 32.10. In terms of profitability, AHG's ROE is -0.34%, compared to ZGM's ROE of +0.72%. Regarding short-term risk, AHG is less volatile compared to ZGM. This indicates lower risk in terms of short-term price fluctuations for AHG.Check ZGM's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, ZTG has a market cap of 37.8M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while ZTG trades at $3.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas ZTG's P/E ratio is 32.60. In terms of profitability, AHG's ROE is -0.34%, compared to ZTG's ROE of +0.72%. Regarding short-term risk, AHG is less volatile compared to ZTG. This indicates lower risk in terms of short-term price fluctuations for AHG.Check ZTG's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, ZSQR has a market cap of 32.7M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while ZSQR trades at $5.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas ZSQR's P/E ratio is -1.87. In terms of profitability, AHG's ROE is -0.34%, compared to ZSQR's ROE of -0.83%. Regarding short-term risk, AHG is less volatile compared to ZSQR. This indicates lower risk in terms of short-term price fluctuations for AHG.Check ZSQR's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, GIFT has a market cap of 30.7M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while GIFT trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas GIFT's P/E ratio is -2.73. In terms of profitability, AHG's ROE is -0.34%, compared to GIFT's ROE of -0.46%. Regarding short-term risk, AHG is more volatile compared to GIFT. This indicates higher risk in terms of short-term price fluctuations for AHG.Check GIFT's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, HOLO has a market cap of 20.2M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while HOLO trades at $1.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas HOLO's P/E ratio is -0.02. In terms of profitability, AHG's ROE is -0.34%, compared to HOLO's ROE of -0.02%. Regarding short-term risk, AHG is more volatile compared to HOLO. This indicates higher risk in terms of short-term price fluctuations for AHG.Check HOLO's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, SST has a market cap of 18.4M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while SST trades at $1.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas SST's P/E ratio is -0.20. In terms of profitability, AHG's ROE is -0.34%, compared to SST's ROE of -3.33%. Regarding short-term risk, AHG is less volatile compared to SST. This indicates lower risk in terms of short-term price fluctuations for AHG.Check SST's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, TGHL has a market cap of 17M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while TGHL trades at $0.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas TGHL's P/E ratio is -1.16. In terms of profitability, AHG's ROE is -0.34%, compared to TGHL's ROE of +7.44%. Regarding short-term risk, AHG is less volatile compared to TGHL. This indicates lower risk in terms of short-term price fluctuations for AHG.Check TGHL's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, AGAE has a market cap of 16.6M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while AGAE trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas AGAE's P/E ratio is -0.54. In terms of profitability, AHG's ROE is -0.34%, compared to AGAE's ROE of -0.76%. Regarding short-term risk, AHG is less volatile compared to AGAE. This indicates lower risk in terms of short-term price fluctuations for AHG.Check AGAE's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, FNGR has a market cap of 16.2M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while FNGR trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas FNGR's P/E ratio is -2.04. In terms of profitability, AHG's ROE is -0.34%, compared to FNGR's ROE of -0.47%. Regarding short-term risk, AHG is less volatile compared to FNGR. This indicates lower risk in terms of short-term price fluctuations for AHG.Check FNGR's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, CHAI has a market cap of 8.7M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while CHAI trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas CHAI's P/E ratio is 0.04. In terms of profitability, AHG's ROE is -0.34%, compared to CHAI's ROE of -3.61%. Regarding short-term risk, AHG is less volatile compared to CHAI. This indicates lower risk in terms of short-term price fluctuations for AHG.Check CHAI's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, QCLS has a market cap of 5.7M. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while QCLS trades at $3.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas QCLS's P/E ratio is -1.20. In terms of profitability, AHG's ROE is -0.34%, compared to QCLS's ROE of -0.65%. Regarding short-term risk, AHG is more volatile compared to QCLS. This indicates higher risk in terms of short-term price fluctuations for AHG.Check QCLS's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, DST has a market cap of 0. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while DST trades at $83.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas DST's P/E ratio is N/A. In terms of profitability, AHG's ROE is -0.34%, compared to DST's ROE of +0.38%. Regarding short-term risk, AHG is more volatile compared to DST. This indicates higher risk in terms of short-term price fluctuations for AHG.Check DST's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, FUEL has a market cap of 0. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while FUEL trades at $2.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas FUEL's P/E ratio is -1.76. In terms of profitability, AHG's ROE is -0.34%, compared to FUEL's ROE of -0.59%. Regarding short-term risk, AHG is more volatile compared to FUEL. This indicates higher risk in terms of short-term price fluctuations for AHG.Check FUEL's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, IMPV has a market cap of 0. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while IMPV trades at $55.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas IMPV's P/E ratio is -68.74. In terms of profitability, AHG's ROE is -0.34%, compared to IMPV's ROE of +0.08%. Regarding short-term risk, AHG is more volatile compared to IMPV. This indicates higher risk in terms of short-term price fluctuations for AHG.Check IMPV's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, RMGN has a market cap of 0. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while RMGN trades at $1.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas RMGN's P/E ratio is -1.86. In terms of profitability, AHG's ROE is -0.34%, compared to RMGN's ROE of -0.66%. Regarding short-term risk, AHG is more volatile compared to RMGN. This indicates higher risk in terms of short-term price fluctuations for AHG.Check RMGN's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, DWRE has a market cap of 0. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while DWRE trades at $74.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas DWRE's P/E ratio is -62.71. In terms of profitability, AHG's ROE is -0.34%, compared to DWRE's ROE of -0.13%. Regarding short-term risk, AHG is more volatile compared to DWRE. This indicates higher risk in terms of short-term price fluctuations for AHG.Check DWRE's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, CSC has a market cap of 0. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while CSC trades at $10.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas CSC's P/E ratio is -6.61. In terms of profitability, AHG's ROE is -0.34%, compared to CSC's ROE of -0.05%. Regarding short-term risk, AHG is more volatile compared to CSC. This indicates higher risk in terms of short-term price fluctuations for AHG.Check CSC's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, XTLY has a market cap of 0. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while XTLY trades at $15.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas XTLY's P/E ratio is -28.98. In terms of profitability, AHG's ROE is -0.34%, compared to XTLY's ROE of -2.17%. Regarding short-term risk, AHG is more volatile compared to XTLY. This indicates higher risk in terms of short-term price fluctuations for AHG.Check XTLY's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, CALD has a market cap of 0. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while CALD trades at $36.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas CALD's P/E ratio is -115.41. In terms of profitability, AHG's ROE is -0.34%, compared to CALD's ROE of -0.08%. Regarding short-term risk, AHG is more volatile compared to CALD. This indicates higher risk in terms of short-term price fluctuations for AHG.Check CALD's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, ACTA has a market cap of 0. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while ACTA trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas ACTA's P/E ratio is 0.18. In terms of profitability, AHG's ROE is -0.34%, compared to ACTA's ROE of -0.07%. Regarding short-term risk, AHG is less volatile compared to ACTA. This indicates lower risk in terms of short-term price fluctuations for AHG.Check ACTA's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, DWCH has a market cap of 0. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while DWCH trades at $13.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas DWCH's P/E ratio is -15.29. In terms of profitability, AHG's ROE is -0.34%, compared to DWCH's ROE of -0.31%. Regarding short-term risk, AHG is more volatile compared to DWCH. This indicates higher risk in terms of short-term price fluctuations for AHG.Check DWCH's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, CRTN has a market cap of 0. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while CRTN trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas CRTN's P/E ratio is -0.63. In terms of profitability, AHG's ROE is -0.34%, compared to CRTN's ROE of -1.79%. Regarding short-term risk, AHG is more volatile compared to CRTN. This indicates higher risk in terms of short-term price fluctuations for AHG.Check CRTN's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, HDP has a market cap of 0. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while HDP trades at $14.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas HDP's P/E ratio is -6.88. In terms of profitability, AHG's ROE is -0.34%, compared to HDP's ROE of +7.62%. Regarding short-term risk, AHG is more volatile compared to HDP. This indicates higher risk in terms of short-term price fluctuations for AHG.Check HDP's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, PRGY has a market cap of 0. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while PRGY trades at N/A.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas PRGY's P/E ratio is N/A. In terms of profitability, AHG's ROE is -0.34%, compared to PRGY's ROE of +3.63%. Regarding short-term risk, AHG is not fully comparable compared to PRGY. This indicates unavailable risk data in terms of short-term price fluctuations for AHG.Check PRGY's competition here

Akso Health Group (NASDAQ: AHG) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHG stands at 143M. In comparison, CRA has a market cap of 0. Regarding current trading prices, AHG is priced at $1.51 on the NASDAQ, while CRA trades at N/A.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHG currently has a P/E ratio of -7.07, whereas CRA's P/E ratio is N/A. In terms of profitability, AHG's ROE is -0.34%, compared to CRA's ROE of -0.59%. Regarding short-term risk, AHG is not fully comparable compared to CRA. This indicates unavailable risk data in terms of short-term price fluctuations for AHG.Check CRA's competition here